全文获取类型
收费全文 | 493篇 |
免费 | 29篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 9篇 |
妇产科学 | 26篇 |
基础医学 | 50篇 |
口腔科学 | 9篇 |
临床医学 | 36篇 |
内科学 | 150篇 |
皮肤病学 | 9篇 |
神经病学 | 62篇 |
特种医学 | 23篇 |
外科学 | 34篇 |
综合类 | 3篇 |
预防医学 | 33篇 |
药学 | 46篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 12篇 |
2022年 | 1篇 |
2021年 | 5篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2018年 | 10篇 |
2017年 | 4篇 |
2016年 | 10篇 |
2015年 | 8篇 |
2014年 | 10篇 |
2013年 | 17篇 |
2012年 | 24篇 |
2011年 | 31篇 |
2010年 | 19篇 |
2009年 | 18篇 |
2008年 | 29篇 |
2007年 | 32篇 |
2006年 | 36篇 |
2005年 | 25篇 |
2004年 | 30篇 |
2003年 | 29篇 |
2002年 | 26篇 |
2001年 | 22篇 |
2000年 | 19篇 |
1999年 | 25篇 |
1998年 | 5篇 |
1997年 | 8篇 |
1996年 | 4篇 |
1995年 | 1篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 7篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1985年 | 7篇 |
1984年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1970年 | 1篇 |
1969年 | 2篇 |
1968年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有522条查询结果,搜索用时 15 毫秒
21.
22.
23.
J P Nater N H Groenman B G Wakkers-Garritsen L H Timmer 《The Journal of prosthetic dentistry》1978,40(4):367-373
A total of 24 patients, 19 women and 5 men, complaining of denture sore mouth was studied. In part I the following investigations were performed: (1) Mechanical factors were evaluated. (2) Temperature was measured beneath the prosthetic denture. (3) Yeast cultures were made. (4) Patch tests with possible allergens were performed on the buccal mucosa and on the skin of the back. In all these investigations there were no significant differences from the results obtained in a control group. In part II the connection between psychological factors and denture sore mouth was explored. Test results of the denture sore mouth group and a matched control group were compared. The obtained data suggest that complaining behavior concerning somatic symptoms in general, on a neurotic base, is a psychological characteristic of denture sore mouth patients. 相似文献
24.
25.
26.
Weinbrenner A Hüneke D Zschiesche M Engel G Timmer W Steinijans VW Bethke T Wurst W Drollmann A Kaatz HJ Siegmund W 《The Journal of clinical endocrinology and metabolism》2002,87(5):2160-2163
The new inhalative glucocorticoid ciclesonide which is activated in lung to a more potent metabolite was hypothesized to have low risk for systemic and local side-effects in man. Therefore, a placebo-controlled, randomized, double-blind, four-period, change-over equivalence study in 12 healthy male volunteers (age 21-28 yr, body weight 62-90 kg) was conducted to assess the influence of three dosage regimens (800 microg in the morning, 800 microg in the evening, 400 microg twice daily for 7 d, metered inhalers) on the circadian time serum cortisol rhythm. RESULTS: Serum cortisol showed the typical circadian rhythm. The geometric mean of the 24-h mesor (AUC((0-24 h))/24 h) was 7.22 microg/dl for placebo, 6.75 microg/dl for the 800 microg ciclesonide morning dose, 7.08 microg/dl for the 800 microg evening dose, and 6.75 microg/dl for 400 microg ciclesonide inhaled twice daily. Because there was also no influence on cortisol amplitude and acrophase (time of maximum), the profiles after ciclesonide were equivalent to the placebo control. The small differences were considered not to be of clinical significance. In conclusion, inhaled ciclesonide in daily doses of 800 microg for 7 d is without clinically relevant effects on the hypothalamic-pituitary-adrenal axis independent of the time of administration. 相似文献
27.
In an open-label, randomized, crossover study, the pharmacokinetics of gepirone immediate-release (gepirone-IR) and different gepirone extended-release (gepirone-ER, types 1, 2, and 3) formulations were compared. Mean maximum concentration (C(max)) was 6.1 ng/mL for gepirone-IR, which was statistically significantly (p < 0.05) higher than that of two of the ER-formulations (3.7 and 3.6 ng/mL, respectively, for types 2 and 3). The mean time to C(max) (mean T(max)) was 1.3 h for gepirone-IR and ranged from 4.8 to 5.6 h for gepirone-ER. The mean area under the curve of concentration versus time (AUC(30)) was similar and not statistically significantly different between gepirone-IR and ER. For the 1-(2-pyrimidinyl)-piperazine (1-PP) metabolite, C(max) and AUC(30) were statistically significantly (p < 0.05) higher and T(max) was lower for gepirone-IR compared with ER. No significant differences in bioavailability were observed between the IR and the three gepirone-ER formulations, indicating that any of the once-daily gepirone-ER formulations could be substituted for gepirone-IR. This study revealed a reduction in the peak-to-trough fluctuations in plasma gepirone concentrations and maintenance of consistent plasma levels with gepirone-ER. 相似文献
28.
29.
The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis 总被引:5,自引:0,他引:5
Schmidt BM Kusma M Feuring M Timmer WE Neuhäuser M Bethke T Stuck BA Hörmann K Wehling M 《The Journal of allergy and clinical immunology》2001,108(4):530-536
BACKGROUND: The beneficial effects of phosphodiesterase 4 (PDE4) inhibitors in allergic asthma have been shown in previous preclinical and clinical studies. Because allergic rhinitis and asthma share several epidemiologic and pathophysiologic factors, PDE4 inhibitors might also be effective in allergic rhinitis. OBJECTIVE: The main objective of this study was to investigate the efficacy of oral roflumilast (500 microg/day) in allergic rhinitis. METHODS: In a randomized, placebo-controlled, double-blinded, crossover study, 25 subjects (16 male, 9 female; median age, 28 years) with histories of allergic rhinitis but asymptomatic at screening received roflumilast (500 microg once daily) and placebo for 9 days each with a washout period of at least 14 days in between treatment periods. In each of the treatment periods, controlled intranasal allergen provocation with pollen extracts was performed daily beginning the third day of treatment, each time approximately 2 hours after study drug administration. Five and 30 minutes after each allergen provocation, rhinal airflow was measured by means of anterior rhinomanometry and the subjective symptoms obstruction, itching, and rhinorrhea were assessed by means of a standardized visual analog scale. RESULTS: Rhinal airflow improved almost consistently during the 9 days of roflumilast treatment, and it was significantly higher at study day 9 on roflumilast in comparison with placebo, a result also found for itching and rhinorrhea. With respect to the subjective obstruction score, a significant difference in comparison with placebo could be demonstrated within 4 days. CONCLUSION: This study shows that a PDE4 inhibitor, roflumilast, effectively controls symptoms of allergic rhinitis. Thus PDE4 inhibitors might be a future treatment option not only in allergic asthma but also in allergic rhinitis or the combination of the 2 diseases. 相似文献
30.
Lindemann M Raethjen J Timmer J Deuschl G Pfister G 《Journal of neuroscience methods》2001,111(2):127-139
In neurophysiology, time delays between concurrently measured time series are usually estimated from the slope of a straight line fitted to the phase spectrum. We point out that this estimate is valid only in the case in which, one signal is a mere time-delayed copy of the other one. We present a procedure for delay estimation that applies to a much wider class of systems with nontrivial phase spectrum like for example lowpass filters. The procedure is based on the Hilbert transform relation between the phase of a linear system and its log gain. The Hilbert transform relation is nonlocal in frequency space, a fact that limits its applicability to experimental data. We explore these limits, and demonstrate that the method is applicable to neurophysiological time series. We present the successful application of the Hilbert transform behavior method to concurrently recorded epicortical brain activity and peripheral tremor. We point out and explain physiologically unreasonable delay estimates given by the traditional method. Finally, we discuss the assumptions underlying the applicability of the Hilbert transform method in the neuroscience context. 相似文献